UnknownNot Applicable

Diffusion MRI in Cervical Spondylotic Myelopathy

China200 participantsStarted 2020-09-01

Plain-language summary

diffusion MRI in evaluates and predicts prognosis in CSM

Who can participate

Age range30 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ages ranged 30-75 * compliance to MRI scan * no MRI contraindication * (Patients) clinical diagnosis of CSM and surgery in our hospital * (Healthy controls) no spinal cord dysfunction Exclusion Criteria: * prior head or neck surgery or accompanying diseases with neurologic deficits and/or symptoms including multiple sclerosis, spinal cord injury, motor neuron disease, or spinal cord tumour * images with motion artifact

What they're measuring

Postoperative neurologic improvement

Timeframe: 3-month, 6-month, 12-month, and 24-month

diagnosis of CSM

Timeframe: at baseline

Trial details

NCT IDNCT04952831

SponsorPeking University Third Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-09-01

View on ClinicalTrials.gov More Cervical Spondylotic Myelopathy trials